Our Team
We are a multidisciplinary team of clinicians and scientists dedicated to advancing liver and metabolic health through research, innovation, and collaboration. Our collective expertise spans a wide range of interests—from metabolic diseases and metabolic dysfunction–associated steatotic liver disease (MASLD) to liver cirrhosis, liver cancer, and transplantation. Our team also includes specialists in radiology and cardiology, enabling us to evaluate metabolic health in a more comprehensive and holistic manner. Together, we bridge basic science and clinical care to better understand disease mechanisms, improve diagnosis, and develop targeted therapies that benefit patients across the spectrum of cardiometabolic and liver disease.
A/Prof Mark Muthiah
Research Focus: MASLD
Dr. Mark Muthiah is a clinician-scientist and Associate Professor at NUS Medicine. His research focuses on metabolic liver diseases, cirrhosis, and liver cancer, with particular interest in biomarker discovery, therapeutic targets, and translational strategies to improve patient outcomes.
Dr Benjamin Nah
Research Focus: Alcohol-related liver disease (ArLD), Metabolic dysfunction-associated steatotic liver disease with increased alcohol intake (MetALD)
Associate Consultant in the Division of Gastroenterology and Hepatology at Alexandra Hospital and National University Hospital, part of the National University Health System (NUHS), Singapore. Clinical scope includes general hepatology and liver transplantation, with a subspecialty focus on alcohol use disorder and alcohol-related liver disease.